Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ka Yang

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Cell|March 21, 2025
Turnover atlas of proteome and phosphoproteome across mouse tissues and brain regionsWenxue Li, Abhijit Dasgupta, Ka Yang, et al.
Scientific Reports|December 8, 2016
Cell studies of hybridized carbon nanofibers containing bioactive glass nanoparticles using bone mesenchymal stromal cellsXiu-Rui Zhang, Xiao-Qing Hu, Xiao-Long Jia, et al.
Journal of Medicinal Chemistry|June 29, 2026
Aryl Aldehyde-Anchored Small Molecules Recruit FBXO22 for Targeted Degradation of NSD2Hua Tang, Yaxian Liao, Tsung-Yu Yeh, et al.
Nature Chemical Biology|January 17, 2024
Covalent inhibition of pro-apoptotic BAXMatthew W McHenry, Peiwen Shi, Christina M Camara, et al.
Nature Communications|November 6, 2025
PROTAC repurposing uncovers a noncanonical binding surface that mediates chemical degradation of nuclear receptorsAndrew D Huber, Wenwei Lin, Young-Hwan Jung, et al.
Nature Communications|June 26, 2024
Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradationChrysanthi Kagiou, Jose A Cisneros, Jakob Farnung, et al.
Iscience|July 1, 2026
<i>In vitro</i> recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platformYunhao Zhai, Min Wen Ku, Ka Yang, et al.
Nature Communications|February 11, 2025
Human and mouse proteomics reveals the shared pathways in Alzheimer's disease and delayed protein turnover in the amyloidomeJay M Yarbro, Xian Han, Abhijit Dasgupta, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Potent and Selective SETDB1 Covalent Negative Allosteric Modulator Reduces Methyltransferase Activity in CellsMélanie Uguen, Devan J Shell, Madhushika Silva, et al.
Nature Communications|February 24, 2025
Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cellsMélanie Uguen, Devan J Shell, Madhushika Silva, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cell|March 21, 2025
Turnover atlas of proteome and phosphoproteome across mouse tissues and brain regionsWenxue Li, Abhijit Dasgupta, Ka Yang, et al.
Scientific Reports|December 8, 2016
Cell studies of hybridized carbon nanofibers containing bioactive glass nanoparticles using bone mesenchymal stromal cellsXiu-Rui Zhang, Xiao-Qing Hu, Xiao-Long Jia, et al.
Journal of Medicinal Chemistry|June 29, 2026
Aryl Aldehyde-Anchored Small Molecules Recruit FBXO22 for Targeted Degradation of NSD2Hua Tang, Yaxian Liao, Tsung-Yu Yeh, et al.
Nature Chemical Biology|January 17, 2024
Covalent inhibition of pro-apoptotic BAXMatthew W McHenry, Peiwen Shi, Christina M Camara, et al.
Nature Communications|November 6, 2025
PROTAC repurposing uncovers a noncanonical binding surface that mediates chemical degradation of nuclear receptorsAndrew D Huber, Wenwei Lin, Young-Hwan Jung, et al.
Nature Communications|June 26, 2024
Alkylamine-tethered molecules recruit FBXO22 for targeted protein degradationChrysanthi Kagiou, Jose A Cisneros, Jakob Farnung, et al.
Iscience|July 1, 2026
<i>In vitro</i> recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platformYunhao Zhai, Min Wen Ku, Ka Yang, et al.
Nature Communications|February 11, 2025
Human and mouse proteomics reveals the shared pathways in Alzheimer's disease and delayed protein turnover in the amyloidomeJay M Yarbro, Xian Han, Abhijit Dasgupta, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Potent and Selective SETDB1 Covalent Negative Allosteric Modulator Reduces Methyltransferase Activity in CellsMélanie Uguen, Devan J Shell, Madhushika Silva, et al.
Nature Communications|February 24, 2025
Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cellsMélanie Uguen, Devan J Shell, Madhushika Silva, et al.
Pageof 5